1. Home
  2. GABC vs ELVN Comparison

GABC vs ELVN Comparison

Compare GABC & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GABC
  • ELVN
  • Stock Information
  • Founded
  • GABC 1910
  • ELVN 2016
  • Country
  • GABC United States
  • ELVN United States
  • Employees
  • GABC N/A
  • ELVN N/A
  • Industry
  • GABC Major Banks
  • ELVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • GABC Finance
  • ELVN Health Care
  • Exchange
  • GABC Nasdaq
  • ELVN Nasdaq
  • Market Cap
  • GABC 1.2B
  • ELVN 1.1B
  • IPO Year
  • GABC N/A
  • ELVN 2020
  • Fundamental
  • Price
  • GABC $38.90
  • ELVN $21.00
  • Analyst Decision
  • GABC Buy
  • ELVN Strong Buy
  • Analyst Count
  • GABC 4
  • ELVN 5
  • Target Price
  • GABC $46.00
  • ELVN $37.80
  • AVG Volume (30 Days)
  • GABC 117.1K
  • ELVN 213.5K
  • Earning Date
  • GABC 04-28-2025
  • ELVN 03-17-2025
  • Dividend Yield
  • GABC 2.98%
  • ELVN N/A
  • EPS Growth
  • GABC N/A
  • ELVN N/A
  • EPS
  • GABC 2.83
  • ELVN N/A
  • Revenue
  • GABC $250,476,000.00
  • ELVN N/A
  • Revenue This Year
  • GABC $42.75
  • ELVN N/A
  • Revenue Next Year
  • GABC $7.67
  • ELVN N/A
  • P/E Ratio
  • GABC $13.76
  • ELVN N/A
  • Revenue Growth
  • GABC 0.94
  • ELVN N/A
  • 52 Week Low
  • GABC $31.06
  • ELVN $10.90
  • 52 Week High
  • GABC $47.08
  • ELVN $30.03
  • Technical
  • Relative Strength Index (RSI)
  • GABC 40.13
  • ELVN 47.82
  • Support Level
  • GABC $39.00
  • ELVN $18.67
  • Resistance Level
  • GABC $40.33
  • ELVN $22.36
  • Average True Range (ATR)
  • GABC 0.83
  • ELVN 1.07
  • MACD
  • GABC -0.09
  • ELVN 0.06
  • Stochastic Oscillator
  • GABC 28.33
  • ELVN 60.84

About GABC German American Bancorp Inc.

German American Bancorp Inc is a bank holding company. The Company's lines of business include Retail and commercial banking business which involves attracting deposits from the general public and using those funds to originate consumer, commercial and agricultural, commercial and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services which involve providing trust, investment advisory, brokerage and retirement planning services to customers. Insurance operations include the offering of a full range of personal and corporate property and casualty insurance products.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.

Share on Social Networks: